Icon

LACRISERT (nda018771)- (5MG)

HYDROXYPROPYL CELLULOSE BAUSCH AND LOMB INC
5MG
No No
Expired Expired
None None
None No
LACRISERT is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with: Exposure keratitis, Decreased corneal sensitivity, Recurrent corneal erosions.
0 0 0
Total Other Developers None
Drugs with Suitability No
5MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.